Sperstent

· FrontAce Scientific Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sperstent, covering 2024-08-06 to 2024-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries [NA]